Horizon Discovery Group plc Grant of Options (9834B)

TIDMHZD

RNS Number : 9834B

Horizon Discovery Group plc

07 April 2017

Grant of options under the Horizon Discovery Group plc Long Term Incentive Plan (the "LTIP")

Cambridge, UK, 7 April 2017: Horizon Discovery Group plc (LSE: HZD), the world leader in the application of gene editing technologies, announces that the following options were granted today over the Company's ordinary shares of 1 pence each ("Ordinary Shares") to Directors in line with the Company's Long Term Incentive Plan:

   Director                         Number of Ordinary Shares over which options granted 
   Darrin Disley                  70,040 
   Richard Vellacott            51,851 

One third of the options will vest on each of the second, third and fourth anniversaries of the date of grant. The options have an exercise price of 1 pence per share. The options granted are equivalent to 0.1 percent of the Company's existing issued share capital.

For further information, please contact:

Consilium Strategic Communications (Financial Media and Investor Relations)

Mary-Jane Elliott / Susan Stuart / Matthew Neal / Melissa Gardiner

Tel: [phone]

Email: [e-mail]

Numis Securities Limited (Joint Broker and NOMAD)

Michael Meade / Freddie Barnfield

Tel: [phone]

RBC Capital Markets (Joint Broker)

Paul Tomasic / Marcus Jackson

Tel: [phone]

About Horizon Discovery Group plc www.horizondiscovery.com/

Horizon Discovery Group plc (LSE: HZD) ("Horizon"), is a world-leading gene editing company that designs and engineers genetically-modified cells and then applies them in research and clinical applications that advance human health.

Horizon's core capabilities are built around its proprietary translational genomics platform, a highly precise and flexible suite of gene editing tools (rAAV, ZFN and CRISPR) able to alter almost any gene sequence in human or mammalian cell-lines.

Horizon offers over 23,000 catalogue products and related research services, almost all of which are based on the generation and application of cell and animal models that accurately recapitulate the disease-causing genetic anomalies found in diseases like cancer. Horizon's commercial offering has been adopted by c1,600 unique research organisations in over 50 countries as well as in the Company's own R&D pipeline to support: a greater understanding of the genetic drivers of disease and the development of molecular, cell and gene therapies that can be prescribed on a personalised basis.

Horizon is headquartered in Cambridge, UK, and is listed on the London Stock Exchange's AIM market under the ticker "HZD"

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------ 
 a)   Name                      Darrin Disley 
---  ------------------------  ---------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position/status           Chief Executive Officer 
---  ------------------------  ---------------------------------- 
 b)   Initial notification      Initial Notification 
       /Amendment 
---  ------------------------  ---------------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                      Horizon Discovery Group plc 
---  ------------------------  ---------------------------------- 
 b)   LEI                       213800L812B9NI5M3G89 
---  ------------------------  ---------------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------ 
 a)   Description of            Ordinary shares of 1 pence 
       the financial             each 
       instrument, type 
       of instrument 
                                 GB00BK8FL363 
       Identification 
       code 
---  ------------------------  ---------------------------------- 
 b)   Nature of the             Grant of share options 
       transaction 
---  ------------------------  ---------------------------------- 
 c)   Price(s) and                Price(s)             Volume(s) 
       volume(s)                  -------------------  ---------- 
                                   1 pence (exercise 
                                    price)              70,040 
                                  -------------------  ---------- 
---  ------------------------  ---------------------------------- 
 d)   Aggregated information 
 
       - Aggregated               n/a 
       volume 
 
       - Price 
---  ------------------------  ---------------------------------- 
 e)   Date of the transaction   07 April 2017 
---  ------------------------  ---------------------------------- 
 f)   Place of the              Outside a trading venue 
       transaction 
---  ------------------------  ---------------------------------- 
 
 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------ 
 a)   Name                      Richard Vellacott 
---  ------------------------  ---------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position/status           Chief Financial Officer 
---  ------------------------  ---------------------------------- 
 b)   Initial notification      Initial Notification 
       /Amendment 
---  ------------------------  ---------------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                      Horizon Discovery Group plc 
---  ------------------------  ---------------------------------- 
 b)   LEI                       213800L812B9NI5M3G89 
---  ------------------------  ---------------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------ 
 a)   Description of            Ordinary shares of 1 pence 
       the financial             each 
       instrument, type 
       of instrument 
                                 GB00BK8FL363 
       Identification 
       code 
---  ------------------------  ---------------------------------- 
 b)   Nature of the             Grant of share options 
       transaction 
---  ------------------------  ---------------------------------- 
 c)   Price(s) and                Price(s)             Volume(s) 
       volume(s)                  -------------------  ---------- 
                                   1 pence (exercise 
                                    price)              51,851 
                                  -------------------  ---------- 
---  ------------------------  ---------------------------------- 
 d)   Aggregated information 
 
       - Aggregated               n/a 
       volume 
 
       - Price 
---  ------------------------  ---------------------------------- 
 e)   Date of the transaction   07 April 2017 
---  ------------------------  ---------------------------------- 
 f)   Place of the              Outside a trading venue 
       transaction 
---  ------------------------  ---------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEDLFBDZFEBBQ

(END) Dow Jones Newswires

April 07, 2017 12:01 ET (16:01 GMT)